Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results.

JAMA network open - 1 Nov 2019

Beckmann Kerri, Crawley Danielle, Nordström Tobias, Aly Markus, Olsson Henrik, Lantz Anna, Binti Abd Jalal Noor, Garmo Hans, Adolfsson Jan, Eklund Martin, Van Hemelrijck Mieke

Abstract excerpt

Importance: Diabetic men appear to have a lower risk of prostate cancer. Whether antidiabetic medications are protective or potentially mask prostate cancer by lowering prostate-specific antigen (PSA) levels is unclear. Objective: To examine the associations of antidiabetic medication use with (1) PSA levels, (2) frequency of PSA testing, (3) receipt of biopsy following elevated PSA results, and (4) prostate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes Mellitus
Share to Educational Status

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypoglycemic Agents

Share to Metformin

Share to Prostate

Share to Prostate-Specific Antigen

Share to Sulfonylurea Compounds

Share to Sweden

Source

Open in PubMed Open full text

Identifiers

PMID: 31693126
DOI: 10.1001/jamanetworkopen.2019.14689
PMCID: PMC6865613

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results.PMID 31693126Read ↗

Reduced risk of prostate cancer in a cohort of Lithuanian diabetes patientsSemantic proximity Read ↗

Association between metformin medication, genetic variation and prostate cancer risk.Semantic proximity Read ↗

Mendelian randomization revealing the protective effect of sodium-glucose cotransporter 2 inhibition on prostate cancer with verified evidence from electronic healthcare and biological dataSemantic proximity Read ↗

Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study.Semantic proximity Read ↗

Metabolic Syndrome and Prostate Cancer: a Review of Complex Interplay Amongst Various Endocrine Factors in the Pathophysiology and Progression of Prostate Cancer.Semantic proximity Read ↗

Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging.Semantic proximity Read ↗

Pharmacological targets of SGLT2 inhibition on prostate cancer mediated by circulating metabolites: a drug-target Mendelian randomization studySemantic proximity Read ↗

Circulating insulin-like growth factor-I, total and free testosterone concentrations and prostate cancer risk in 200,000 men in UK BiobankSemantic proximity Read ↗

Report prepared for the Health Technology Assessment panel of the NHS Executive on the diagnosis, management, treatment and costs of prostate cancer in England and Wales.Semantic proximity Read ↗

The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort.Semantic proximity Read ↗

Prostate cancer screening, changing age-specific incidence trends and implications on familial risk.Semantic proximity Read ↗

Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.